Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

NET

  • Safety and Efficacy of <em>Para</em>-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
    You have access
    Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
    Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann and Miriam Sraieb
    Journal of Nuclear Medicine June 1, 2024, 65 (6) 931-937; DOI: https://doi.org/10.2967/jnumed.123.266619
  • Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumors
    You have access
    Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of 177Lu-DOTATATE in Neuroendocrine Tumors
    Lisa Bodei, Nitya Raj, Richard K. Do, Audrey Mauguen, Simone Krebs, Diane Reidy-Lagunes and Heiko Schöder
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 567-573; DOI: https://doi.org/10.2967/jnumed.122.264363
  • Targeted <strong>α</strong>-Emitter Therapy with <sup>212</sup>Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial
    You have access
    Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial
    Ebrahim S. Delpassand, Izabela Tworowska, Rouzbeh Esfandiari, Julien Torgue, Jason Hurt, Afshin Shafie and Rodolfo Núñez
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1326-1333; DOI: https://doi.org/10.2967/jnumed.121.263230
  • You have access
    Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
    Valentina Ambrosini, Davide Campana, Giulia Polverari, Chiara Peterle, Stefania Diodato, Claudio Ricci, Vincenzo Allegri, Riccardo Casadei, Paola Tomassetti and Stefano Fanti
    Journal of Nuclear Medicine December 1, 2015, 56 (12) 1843-1848; DOI: https://doi.org/10.2967/jnumed.115.162719
  • You have access
    Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
    Ken Herrmann, Johannes Czernin, Edward M. Wolin, Pawan Gupta, Martin Barrio, Antonio Gutierrez, Christiaan Schiepers, Sherly Mosessian, Michael E. Phelps and Martin S. Allen-Auerbach
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 70-75; DOI: https://doi.org/10.2967/jnumed.114.148247
  • You have access
    Assessment of the 18F-Labeled PET Tracer LMI1195 for Imaging Norepinephrine Handling in Rat Hearts
    Takahiro Higuchi, Behrooz H. Yousefi, Franz Kaiser, Florian Gärtner, Christoph Rischpler, Sybille Reder, Ming Yu, Simon Robinson, Marcus Schwaiger and Stephan G. Nekolla
    Journal of Nuclear Medicine July 1, 2013, 54 (7) 1142-1146; DOI: https://doi.org/10.2967/jnumed.112.104232
SNMMI

© 2025 SNMMI

Powered by HighWire